Indications and uses
• treats frequent heartburn (occurs 2 or more days a week) • not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect
• treats frequent heartburn (occurs 2 or more days a week) • not intended for immediate relief of heartburn; this drug may take 1 to 4 days for full effect
• for adults 18 years of age and older • this product is to be used once a day (every 24 hours), every day for 14 days • it may take 1 to 4 days for full effect; some people get complete relief of symptoms within 24 hours 14-Day Course of Treatment • swallow 1 tablet with a glass of water before eating in the morning • take every day for 14 days • do not take more than 1 tablet a day • do not use for more than 1...
• read the directions and warnings before use • keep the carton. It contains important information. • store at 20-25°C (68-77°F) and protect from moisture
Omeprazole 20 mg
Acid reducer
Allergy alert: Do not use if you are allergic to omeprazole
if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
taking
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
carnauba wax, ferric oxide red, ferric oxide yellow, hypromellose, hypromellose acetate succinate, lactose monohydrate, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, titanium dioxide, triethyl citrate
1-800-719-9260
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 57896-760-42 | EA - Each | 57896-760 | a4d22a21-4d63-4d13-ab94-e7e4b66277d9 | 1 | 2014-01-04 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OMEPRAZOLE | ACTIVE INGREDIENT | KG60484QX9 | 1 | |
| OMEPRAZOLE | ACTIVE MOIETY | KG60484QX9 | 1 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 1 | |
| MONOETHANOLAMINE | INACTIVE INGREDIENT | 5KV86114PT | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 1 | |
| SODIUM STEARATE | INACTIVE INGREDIENT | QU7E2XA9TG | 1 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57896-760 | 57896-760-42 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OMEPRAZOLE | KG60484QX9 | ACTIB |
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| FERRIC OXIDE RED | 1K09F3G675 | IACT |
| FERRIC OXIDE YELLOW | EX438O2MRT | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| SODIUM LAURYL SULFATE | 368GB5141J | IACT |
| SODIUM STEARATE | QU7E2XA9TG | IACT |
| SODIUM STEARYL FUMARATE | 7CV7WJK4UI | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| TRIETHYL CITRATE | 8Z96QXD6UM | IACT |
| MONOETHANOLAMINE | 5KV86114PT | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | 174 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 221 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET, DELAYED RELEASE / ORAL | 120 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER, FOR SUSPENSION / ORAL | 297 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | SHAMPOO / TOPICAL | 65 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAMUSCULAR | 4000 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 7 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | 29008 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | DROPS / ORAL | NA | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, FOR SUSPENSION / ORAL | 264 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | GEL / DENTAL | 1.47 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, COATED / ORAL | 1.18 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE, DELAYED RELEASE / ORAL | 46 mg | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 147 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SOAP / TOPICAL | 1 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / TOPICAL | 4522 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, DELAYED RELEASE / ORAL | 216 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, EXTENDED RELEASE / ORAL | 2575 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | GRANULE, FOR SOLUTION / ORAL | 18.2 mg/120ml | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | POWDER, FOR SUSPENSION / ORAL | NA | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | PELLET / ORAL | 43 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | 9306 mg | ||
| SODIUM STEARYL FUMARATE | SODIUM STEARYL FUMARATE | 7CV7WJK4UI | TABLET, EXTENDED RELEASE / ORAL | 42 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CREAM / VAGINAL | 586 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | PELLET / ORAL | 640 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SHAMPOO, SUSPENSION / TOPICAL | 2 %w/w | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CAPSULE, EXTENDED RELEASE / ORAL | 5364 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | CAPSULE / ORAL | NA | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | GRANULE / ORAL | 12 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / RESPIRATORY (INHALATION) | 25 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, CHEWABLE / ORAL | 14 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, SOLUBLE / BUCCAL | 5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | OINTMENT / TOPICAL | 5 %w/w | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022032-001 | OMEPRAZOLE | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 |
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022032-001 | 12599565 | 2030-01-31 | Drug product | 2026-05-11 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022032-001 | OMEPRAZOLE | 20MG | TABLET, DELAYED RELEASE / ORAL | RLD, RS | 2007-12-04 | 3a93d1ddd44b… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N022032-001 | 12599565 | 2030-01-31 | Drug product | 2026-05-11 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N022032-001 | 12599565 | 2030-01-31 | Drug product | 2026-05-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022032-001 | 12599565 | 2030-01-31 | Drug product | 2026-05-11 | caaa826d4ba7… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N022032-001 | 9023391 | 2025-08-16 | Drug product | 2015-06-03 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2a291447-2840-4e10-9a3a-81a6f4adc8dc | 235b5cab-70e0-4e2f-9ce8-47b1381782c4 | 2021-01-28 | Warnings | 235b5cab-70e0-4e2f-9ce8-47b1381782c4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.